Skip to content

Clinical trials

Completed Observational Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Observational Status: Completed Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20042
20061
20073
20085
20092
20102
20111
20121
20141
20151
20161
20181
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Notal Vision Ltd.6
Bayer3
National Eye Institute (NEI)2
Assistance Publique - Hôpitaux de Paris1
Barnes Retina Institute1
Changhua Christian Hospital1
European Georges Pompidou Hospital1
Federico II University1
Johns Hopkins University1
Kim's Eye Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization26
Macular Degeneration16
Geographic Atrophy2
Angioid Streaks1
Central Serous Chorioretinopathy1
Epiretinal Membrane1
Ornithine Carbamoyltransferase Deficiency Disease1
Polypoidal Choroidal Vasculopathy1
Pseudoxanthoma Elasticum1
Retinal Drusen1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.